A costimulatory function for T cell CD40

Journal of Immunology

Volumn 178, Issue 2, 2007, Pages 671-682

  Munroe, Melissa E ^a   Bishop, Gail A ^a,b,c  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CD40 ANTIGEN; CYTOKINE; LYMPHOCYTE ANTIGEN RECEPTOR; T LYMPHOCYTE RECEPTOR;

ADOLESCENT; ANIMAL CELL; ANTIBODY PRODUCTION; ANTIGEN EXPRESSION; ARTHRITIS; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL ACTIVATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME INDUCTION; FEMALE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; INFLAMMATION; LYMPHOCYTE ACTIVATION; LYMPHOCYTE FUNCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 33846234751     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.178.2.671     Document Type: Article

References (97)

1. Grewal, I. S., and R. A. Flavell. 1996. The role of CD40 ligand in costimulation and T cell activation. Immunol. Rev. 153: 85-106.
2. + T cells in vivo in the absence of other professional antigen-presenting cells in a CD154-CD40-dependent manner. Eur. J. Immunol. 35: 1097-1105.
3. Bishop, G. A., and B. S. Hostager. 2003. The CD40-CD154 interaction in B cell-T cell liaisons. Cytokine Growth Factor Rev. 14: 297-309.
4. Balasa, B., T. Krahl, G. Patstone, J. Lee, R. Tisch, H. O. McDevitt, and N. Sarvetnick. 1997. CD40 ligand-CD40 interactions are necessary for the initiation of insulitis and diabetes in nonobese diabetic mice. J. Immunol. 159: 4620-4627.
5. Durie, F. H., R. A. Fava, T. M. Foy, A. Aruffo, J. A. Ledbetter, and R. J. Noelle. 1993. Prevention of collagen-induced arthritis with an antibody to gp39, the ligand for CD40. Science 261: 1328-1330.
6. Toubi, E., and Y. Shoenfeld. 2004. The role of CD40-CD154 interactions in autoimmunity and the benefit of disrupting this pathway. Autoimmunity 37: 457-464.
7. Datta, S. K. 1998. Production of pathogenic antibodies: cognate interactions between autoimmune T and B cells. Lupus 7: 591-596.
8. Kyburz, D., M. Corr, D. C. Brinson, A. Von Damm, H. Tighe, and D. A. Carson. 1999. Human rheumatoid factor production is dependent on CD40 signaling and autoantigen. J. Immunol. 163: 3116-3122.
9. Fanslow, W. C., K. N. Clifford, M. Seaman, M. R. Alderson, M. K. Spriggs, R. J. Armitage, and F. Ramsdell. 1994. Recombinant CD40 ligand exerts potent biologic effects on T cells. J. Immunol. 152: 4262-4269.
10. + T cell memory. Science 297: 2060-2063.
11. Koschella, M., D. Voehringer, and H. Pircher. 2004. CD40 ligation in vivo induces bystander proliferation of memory phenotype CD8 T cells. J. Immunol. 172: 4804-4811.
12. Lee, B. O., L. Hartson, and T. D. Randall. 2003. CD40-deficient, influenza-specific CD8 memory T cells develop and function normally in a CD40-sufficient environment. J. Exp. Med. 198: 1759-1764.
13. Sun, J. C., and M. J. Bevan. 2004. Cutting edge: long-lived CD8 memory and protective immunity in the absence of CD40 expression on CD8 T cells. J. Immunol. 172: 3385-3389.
14. Wagner, D. H., Jr., E. Newell, R. J. Sanderson, J. H. Freed, and M. K. Newell. 1999. Increased expression of CD40 on thymocytes and peripheral T cells in autoimmunity: a mechanism for acquiring changes in the peripheral T cell receptor repertoire. Int. J. Mol. Med. 4: 231-242.
15. Wagner, D. H., Jr., G. Vaitaitis, R. Sanderson, M. Poulin, C. Dobbs, and K. Haskins. 2002. Expression of CD40 identifies a unique pathogenic T cell population in type 1 diabetes. Proc. Natl. Acad. Sci. USA 99: 3782-3787.
16. Vaitaitis, G. M., M. Poulin, R. J. Sanderson, K. Haskins, and D. H. Wagner Jr. 2003. Cutting edge: CD40-induced expression of recombination activating gene (RAG) 1 and RAG2: a mechanism for the generation of autoaggressive T cells in the periphery. J. Immunol. 170: 3455-3459.
17. + auto-aggressive T cell expansion during insulin-dependent diabetes mellitus. Eur. J. Immunol. 34: 1488-1497.
18. Haxhinasto, S. A., B. S. Hostager, and G. A. Bishop. 2002. Cutting edge: molecular mechanisms of synergy between CD40 and the B cell antigen receptor: role for TNF receptor-associated factor 2 in receptor interaction. J. Immunol. 169: 1145-1149.
19. Bishop, G. A., and B. S. Hostager. 2001. Molecular mechanisms of CD40 signaling. Arch. Immunol. Ther. Exp. 49: 129-137.
20. Bishop, G. A., and B. S. Hostager. 2001. Signaling by CD40 and its mimics in B cell activation. Immunol. Res. 24: 97-109.
21. Croft, M. 2003. Co-stimulatory members of the TNFR family: keys to effective T cell immunity? Nat. Rev. Immunol. 3: 609-620.
22. Watts, T. H. 2005. TNF/TNFR family members in costimulation of T cell responses. Ann. Rev. Immunol. 23: 23-68.
23. Ashwell, J. D., R. E. Cunningham, P. D. Noguchi, and D. Hernandez. 1987. Cell growth cycle block of T cell hybridomas upon activation with antigen. J. Exp. Med. 165: 173-194.
24. Gillis, S., and J. Watson. 1980. Biochemical and biological characterization of lymphocyte regulatory molecules. V. Identification of an interleukin 2-producing human leukemia T cell line. J. Exp. Med. 152: 1709-1719.
25. Warren, W. D., and M. T. Berton. 1995. Induction of germ-line γ1 and ε Ig gene expression in murine B cells-IL-4 and the CD40 ligand-CD40 interaction provide distinct but synergistic signals. J. Immunol. 155: 5637-5646.
26. Bishop, G. A., W. D. Warren, and M. T. Berton. 1995. Signaling via major histocompatibility complex class II molecules and antigen receptors enhances the B cell response to gp39/CD40 ligand. Eur. J. Immunol. 25: 1230-1238.
27. Hostager, B. S., Y. Hsing, D. E. Harms, and G. A. Bishop. 1996. Different CD40-mediated signaling events require distinct CD40 structural features. J. Immunol. 157: 1047-1053.
28. + B cell clone. Proc. Natl. Acad. Sci. USA 86: 5933-5937.
29. b) mice: new insights into an important disease model of rheumatoid arthritis. Eur. J. Immunol. 30: 1568-1575.
30. Rosloniec, E. F., A. H. Kang, L. K. Myers, and M. A. Cremer. 1997. Collagen-Induced Arthritis. Wiley & Sons, New York.
31. Berberich, I., G. L. Shu, and E. A. Clark. 1994. Cross-linking CD40 on B cells rapidly activates nuclear factor κB. J. Immunol. 153: 4357-4366.
32. Schreiber, E., P. Matthias, M. M. Muller, and W. Schaffner. 1989. Rapid detection of octamer binding proteins with "mini-extracts," prepared from a small number of cells. Nucleic Acids Res. 17: 6419.
33. Moore, C. R., and G. A. Bishop. 2005. Differential regulation of CD40-mediated TNF receptor-associated factor degradation in B lymphocytes. J. Immunol. 175: 3780-3789.
34. Xie, P., B. S. Hostager, and G. A. Bishop. 2004. Requirement for TRAF3 in signaling by LMP1 but not CD40 in B lymphocytes. J. Exp. Med. 199: 661-671.
35. Myers, L. K., E. F. Rosloniec, M. A. Cremer, and A. H. Kang. 1997. Collagen-induced arthritis, an animal model of autoimmunity. Life Sci. 61: 1861-1878.
36. Schulze-Koops, H., and J. R. Kalden. 2001. The balance of Th1/Th2 cytokines in rheumatoid arthritis. Best Pract. Res. Clin. Rheumatol. 15: 677-691.
37. Ballester, A., A. Velasco, R. Tobena, and S. Alemany. 1998. Cot kinase activates tumor necrosis factor α gene expression in a cyclosporin A-resistant manner. J. Biol. Chem. 273: 14099-14106.
38. Kashiwakura, J., N. Suzuki, H. Nagafuchi, M. Takeno, Y. Takeba, Y. Shimoyama, and T. Sakane. 1999. Txk, a nonreceptor tyrosine kinase of the Tec family, is expressed in T helper type 1 cells and regulates interferon γ production in human T lymphocytes. J. Exp. Med. 190: 1147-1154.
39. Chung, D. H., K. C. Jung, W. S. Park, I. S. Lee, W. J. Choi, C. J. Kim, S. H. Park, and Y. Bae. 2000. Costimulatory effect of Fas in mouse T lymphocytes. Mol. Cell 10: 642-646.
40. Tibbetts, S. A., C. Chirathaworn, M. Nakashima, D. S. Jois, T. J. Siahaan, M. A. Chan, and S. H. Benedict. 1999. Peptides derived from ICAM-1 and LFA-1 modulate T cell adhesion and immune function in a mixed lymphocyte culture. Transplantation 68: 685-692.
41. Moulian, N., J. Bidault, C. Planche, and S. Berrih-Aknin. 1998. Two signaling pathways can increase fas expression in human thymocytes. Blood 92: 1297-1307.
42. Bhatia, S., M. Edidin, S. C. Almo, and S. G. Nathenson. 2006. B7-1 and B7-2: similar costimulatory ligands with different biochemical, oligomeric and signaling properties. Immunol. Lett. 104: 70-75.
43. Adler, S. H., E. Chiffoleau, L. Xu, N. M. Dalton, J. M. Burg, A. D. Wells, M. S. Wolfe, L. A. Turka, and W. S. Pear. 2003. Notch signaling augments T cell responsiveness by enhancing CD25 expression. J. Immunol. 171: 2896-2903.
44. Cianferoni, A., M. Massaad, S. Feske, M. A. de la Fuente, L. Gallego, N. Ramesh, and R. S. Geha. 2005. Defective nuclear translocation of nuclear factor of activated T cells and extracellular signal-regulated kinase underlies deficient IL-2 gene expression in Wiskott-Aldrich syndrome. J. Allergy Clin. Immunol. 116: 1364-1371.
45. Palanki, M. S. 2002. Inhibitors of AP-1 and NF-κB mediated transcriptional activation: therapeutic potential in autoimmune diseases and structural diversity. Curr. Med. Chem. 9: 219-227.
46. Jain, J., C. Loh, and A. Rao. 1995. Transcriptional regulation of the IL-2 gene. Curr. Opin. Immunol. 7: 333-342.
47. Kaminuma, O., C. Elly, Y. Tanaka, A. Mori, Y. C. Liu, A. Altman, and S. Miyatake. 2002. Vav-induced activation of the human IFN-γ gene promoter is mediated by upregulation of AP-1 activity. FEBS Lett. 514: 153-158.
48. Sica, A., L. Dorman, V. Viggiano, M. Cippitelli, P. Ghosh, N. Rice, and H. A. Young. 1997. Interaction of NF-κB and NFAT with the interferon γ promoter. J. Biol. Chem. 272: 30412-30420.
49. Li-Weber, M., M. K. Treiber, M. Giaisi, K. Palfi, N. Stephan, S. Parg, and P. H. Krammer. 2005. Ultraviolet irradiation suppresses T cell activation via blocking TCR-mediated ERK and NF-κB signaling pathways. J. Immunol. 175: 2132-2143.
50. Baccam, M., S. Y. Woo, C. Vinson, and G. A. Bishop. 2003. CD40-mediated transcriptional regulation of the IL-6 gene in B lymphocytes: involvement of NF-κB, AP-1, and C/EBP. J. Immunol. 170: 3099-3108.
51. Francis, D. A., J. G. Karras, X. Y. Ke, R. Sen, and T. L. Rothstein. 1995. Induction of the transcription factors NF-κB, AP-1 and NF-AT during B cell stimulation through the CD40 receptor. Int. Immunol. 7: 151-161.
52. Hsing, Y., and G. A. Bishop. 1999. Requirement for nuclear factor κB activation by a distinct subset of CD40-mediated effector functions in B lymphocytes. J. Immunol. 162: 2804-2811.
53. Antony, P., J. B. Petro, G. Carlesso, N. P. Shinners, J. Lowe, and W. N. Khan. 2003. B cell receptor directs the activation of NFAT and NF-κB via distinct molecular mechanisms. Exp. Cell Res. 291: 11-24.
54. Brown, K. D., B. S. Hostager, and G. A. Bishop. 2001. Differential signaling and tumor necrosis factor receptor-associated factor (TRAF) degradation mediated by CD40 and the Epstein-Barr virus oncoprotein latent membrane protein 1 (LMP1). J. Exp. Med. 193: 943-954.
55. Li, Y. Y., M. Baccam, S. B. Waters, J. E. Pessin, G. A. Bishop, and G. A. Koretzky. 1996. CD40 ligation results in protein kinase C-independent activation of ERK and JNK in resting murine splenic B cells. J. Immunol. 157: 1440-1447.
56. Munroe, M. E., and G. A. Bishop. 2004. Role of tumor necrosis factor (TNF) receptor-associated factor 2 (TRAF2) in distinct and overlapping CD40 and TNF receptor 2/CD120b-mediated B lymphocyte activation. J. Biol. Chem. 279: 53222-53231.
57. Hsing, Y., B. S. Hostager, and G. A. Bishop. 1997. Characterization of CD40 signaling determinants regulating nuclear factor κB activation in B lymphocytes. J. Immunol. 159: 4898-4906.
58. Coope, H. J., P. G. Atkinson, B. Huhse, M. Belich, J. Janzen, M. J. Holman, G. G. Klaus, L. H. Johnston, and S. C. Ley. 2002. CD40 regulates the processing of NF-KB2 p100 to p52. EMBO J. 21: 5375-5385.
59. Karin, M., and Y. Ben-Neriah. 2000. Phosphorylation meets ubiquitination: the control of NF-κB activity. Ann. Rev. Immunol. 18: 621-663.
60. Bishop, G. A., B. S. Hostager, and K. D. Brown. 2002. Mechanisms of TNF receptor-associated factor (TRAF) regulation in B lymphocytes. J. Leukocyte Biol. 72: 19-23.
61. Hostager, B. S., I. M. Catlett, and G. A. Bishop. 2000. Recruitment of CD40 and tumor necrosis factor receptor-associated factors 2 and 3 to membrane microdomains during CD40 signaling. J. Biol. Chem. 275: 15392-15398.
62. Jalukar, S. V., B. S. Hostager, and G. A. Bishop. 2000. Characterization of the roles of TNF receptor-associated factor 6 in CD40-mediated B lymphocyte effector functions. J. Immunol. 164: 623-630.
63. Hostager, B. S., S. A. Haxhinasto, S. L. Rowland, and G. A. Bishop. 2003. Tumor necrosis factor receptor-associated factor 2 (TRAF2)-deficient B lymphocytes reveal novel roles for TRAF2 in CD40 signaling. J. Biol. Chem. 278: 45382-453890.
64. Xie, P., B. S. Hostager, M. E. Munroe, C. R. Moore, and G. A. Bishop. 2006. Cooperation between TNF receptor-associated factors 1 and 2 in CD40 signaling. J. Immunol. 176: 5388-5400.
65. Kwon, B., B. S. Kim, H. R. Cho, J. E. Park, and B. S. Kwon. 2003. Involvement of tumor necrosis factor receptor superfamily (TNFRSF) members in the pathogenesis of inflammatory diseases. Exp. Mol. Med. 35: 8-16.
66. Lorenz, H. M.. M. Herrmann, and J. R. Kalden. 2001. The pathogenesis of autoimmune diseases. Scand. J. Clin. Lab. Invest. 235: 16-26.
67. Cooper, C. J., G. L. Turk, M. Sun, A. G. Farr, and P. J. Fink. 2004. Cutting edge: TCR revision occurs in germinal centers. J. Immunol. 173: 6532-6536.
68. + T cells. J. Immunol. 176: 3028-3036.
69. Blattman, J. N., R. Antia, D. J. Sourdive, X. Wang, S. M. Kaech, K. Murali-Krishna, J. D. Altman, and R. Ahmed. 2002. Estimating the precursor frequency of naive antigen-specific CD8 T cells. J. Exp. Med. 195: 657-664.
70. Saoulli, K., S. Y. Lee, J. L. Cannons, W. C. Yeh, A. Santana, M. D. Goldstein, N. Bangia, M. A. DeBenedette, T. W. Mak, Y. Choi, and T. H. Watts. 1998. CD28-independent, TRAF2-dependent costimulation of resting T cells by 4-1BB ligand. J. Exp. Med. 187: 1849-1862.
71. Gupta, S. 1989. Mechanisms of transmembrane signalling in human T cell activation. Mol. Cell. Biochem. 91: 45-50.
72. Flescher, E., J. A. Ledbetter, N. Ogawa, N. Vela-Roch, D. Possum, H. Dang, and N. Talal. 1995. Induction of transcription factors in human T lymphocytes by aspirin-like drugs. Cell. Immunol. 160: 232-239.
73. Isakov, N., and A. Altman. 2002. Protein kinase Cθ in T cell activation. Ann. Rev. Immunol. 20: 761-794.
74. Kaykas, A., K. Worringer, and B. Sugden. 2001. CD40 and LMP-1 both signal from lipid rafts but LMP-1 assembles a distinct, more efficient signaling complex. EMBO J. 20: 2641-2654.
75. Kovacs, B., R. V. Parry, Z. Ma, E. Fan, D. K. Shivers, B. A. Freiberg, A. K. Thomas, R. Rutherford, C. A. Rumbley, J. L. Riley, and T. H. Finkel. 2005. Ligation of CD28 by its natural ligand CD86 in the absence of TCR stimulation induces lipid raft polarization in human CD4 T cells. J. Immunol. 175: 7848-7854.
76. Watts, T. H., and M. A. DeBenedette. 1999. T cell co-stimulatory molecules other than CD28. Curr. Opinion. Immunol. 11: 286-293.
77. Nowak, U. M., and M. M. Newkirk. 2005. Rheumatoid factors: good or bad for you? Int. Arch. Allergy Immunol. 138: 180-188.
78. Schlosser, M., K. Koczwara, H. Kenk, M. Strebelow, I. Rjasanowski, R. Wassmuth, P. Achenbach, A. G. Ziegler, and E. Bonifacio. 2005. In insulin-autoantibody-positive children from the general population, antibody affinity identifies those at high and low risk. Diabetologia 48: 1830-1832.
79. Quintana, F. J., and I. R. Cohen. 2004. The natural autoantibody repertoire and autoimmune disease. Biomed. Pharmacother. 58: 276-281.
80. Matsui, K., S. Jodo, S. Xiao, and S. T. Ju. 1999. Hypothesis: a recurrent, moderate activation fosters systemic autoimmunity-the apoptotic roles of TCR, IL-2 and Fas ligand. J. Biomed. Sci. 6: 306-313.
81. Shepshelovich, D., and Y. Shoenfeld. 2006. Prediction and prevention of autoimmune diseases: additional aspects of the mosaic of autoimmunity. Lupus 15: 183-190.
82. Noorchashm, H., S. A. Greeley, and A. Naji. 2003. The role of t/b lymphocyte collaboration in the regulation of autoimmune and alloimmune responses. Immunol. Res. 27: 443-450.
83. Korganow, A. S., H. Ji, S. Mangialaio, V. Duchatelle, R. Pelanda, T. Martin, C. Degott, H. Kikutani, K. Rajewsky, J. L. Pasquali, et al. 1999. From systemic T cell self-reactivity to organ-specific autoimmune disease via immunoglobulins. Immunity 10: 451-461.
84. Brand, D. D., A. H. Kang, and E. F. Rosloniec. 2003. Immunopathogenesis of collagen arthritis. Springer Semin. Immunopathol. 25: 3-18.
85. Haxhinasto, S. A., and G. A. Bishop. 2003. Synergistic B cell activation by CD40 and the B cell antigen receptor: role of BCR-mediated kinase activation and TRAF regulation. J. Biol. Chem. 279: 2575-2582.
86. Haxhinasto, S. A., and G. A. Bishop. 2003. A novel interaction between protein kinase D and TNF receptor-associated factor molecules regulates B cell receptor-CD40 synergy. J. Immunol. 171: 4655-4662.
87. Mizuno, T., and T. L. Rothstein. 2003. Cutting edge: CD40 engagement eliminates the need for Bruton's tyrosine kinase in B cell receptor signaling for NF-κB. J. Immunol. 170: 2806-2810.
88. Mizuno, T., and T. L. Rothstein. 2005. B cell receptor (BCR) cross-talk: CD40 engagement creates an alternate pathway for BCR signaling that activates IκB kinase/IκBα/NF-κB without the need for PI3K and phospholipase Cγ. J. Immunol. 174: 6062-6070.
89. Mizuno, T., and T. L. Rothstein. 2005. B cell receptor (BCR) cross-talk: CD40 engagement enhances BCR-induced ERK activation. J. Immunol. 174: 3369-3376.
90. Ollila, J., and M. Vihinen. 2005. B cells. Int. J. Biochem. Cell Biol. 37: 518-523.
91. Kollias, G., and D. Kontoyiannis. 2002. Role of TNF/TNFR in autoimmunity: specific TNF receptor blockade may be advantageous to anti-TNF treatments. Cytokine Growth Factor Rev. 13: 315-321.
92. Hostager, B. S., and G. A. Bishop. 2002. Role of TNF receptor-associated factor 2 in the activation of IgM secretion by CD40 and CD120b. J. Immunol. 168: 3318-3322.
93. Kim, E. Y., and H. S. Teh. 2004. Critical role of TNF receptor type-2 (p75) as a costimulator for IL-2 induction and T cell survival: a functional link to CD28. J. Immunol. 173: 4500-4509.
94. Kim, E. Y., and H. S. Teh. 2001. TNF type 2 receptor (p75) lowers the threshold of T cell activation. J. Immunol. 167: 6812-6820.
95. Aspalter, R. M., M. M. Eibl, and H. M. Wolf. 2003. Regulation of TCR-mediated T cell activation by TNF-RII. J. Leukocyte Biol. 74: 572-582.
96. Girvin, A. M., M. C. Dal Canto, and S. D. Miller. 2002. CD40/CD40L interaction is essential for the induction of EAE in the absence of CD28-mediated co-stimulation. J. Autoimmun. 18: 83-94.
97. Pollard, K. M., M. Arnush, P. Hultman, and D. H. Kono. 2004. Costimulation requirements of induced murine systemic autoimmune disease. J. Immunol. 173: 5880-5887.